This finding was consistent with that of the abovementioned study by Woolston et al., which reported that high TxNIP expression was significantly associated with distant metastasis-free survival (p = 0.021) and overall survival (p = 0.037) in patients with breast cancer [27]. The gene discussed is TXNIP; the disease is breast carcinoma.